Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value
$203.50M
Total Bought
$3.56M
Total Sold
$1.76M
Net Transaction
+$1.80M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Dyne Therapeutics, Inc.(DYN)4,951,3034,951,303044,36465,85232.36%+21,489
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,284,17209,16816,5378.13%+7,369
Harpoon Therapeutics, Inc.0313,136+313,13603,5601.75%+3,560
iTeos Therapeutics, Inc.2,738,7852,738,785029,99029,99014.74%0
Adaptimmune Therapeutics plc(ADAPY)6,287,1015,555,461-731,6404,9044,4052.16%-498
Harpoon Therapeutics, Inc.313,1360-313,1361,2620—-1,262
Entrada Therapeutics, Inc.(TRDA)4,425,7844,425,784069,92766,78532.82%-3,142
Repare Therapeutics, Inc.2,242,6362,242,636027,09116,3718.04%-10,720
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q4 2023 | TickerTrail